Activity Overview
This educational activity is an archive
of the live conference held from January 23 to 25, 2026.
Target Audience
This educational activity is intended for oncologists involved in
the treatment and management of patients with lung cancer. Nurse practitioners,
nurses, physician assistants, pharmacists, clinical investigators, fellows, and
other health care professionals interested in the treatment of lung cancer may
also participate.
Learning Objectives
- Apply current evidence-based, guideline-recommended approaches to biomarker testing to inform treatment selection in patients with lung cancer.
Mark A. Socinski, MD
Executive Medical Director
Member, Thoracic Oncology Program
AdventHealth Cancer Institute
Orlando, FL
Fred Hirsch, MD, PhD, FASCO
Professor of Medicine and Pathology
Ning Zhao Chair Professor in Lung Cancer
Executive Director, Center for Thoracic Oncology
Associate Director of Biomarker Discovery, Tisch Cancer Institute
Icahn School of Medicine at Mount Sinai
New York, NY
Hossein Borghaei, DO, MS
Professor, Department of Hematology/Oncology
Chief, Division of Thoracic Medical Oncology
Fox Chase Cancer Center
Philadelphia, PA
Benjamin Creelan, MD
Associate Professor
Associate Member, Moffitt Cancer Center
University of South Florida
Tampa, FL
Please click here to view disclosures for faculty and the staff of Physicians’ Education Resource®.
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here
